Biomea Fusion

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.61-$20.21
Market Cap
$153.2M
Shares Short
9M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$4.01

News

See more

Yahoo Finance • last year

Biomea Fusion Announces Acceptance of Three Abstracts for its Novel Menin Inhibitor Highlighting Durable Glycemic Control in Diabetes Patients at the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in 2024

Yahoo Finance • last year

Biomea Fusion Abstract “BMF-219: A Novel Therapeutic Agent to Reestablish Functional Beta Cells and Provide Long-term Glycemic Control" Selected as One of Six Oral Presentations at 21st World Congress Insulin Resistance, Diabetes & Cardiovascular Disease

Yahoo Finance • last year

Biomea Fusion to Present New Data from Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes at the World Congress Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)

Yahoo Finance • last year

Biomea Fusion Announces Two Poster Presentations at Upcoming ASH Annual Meeting 2023

About

CEO
Mr. Thomas Andrew Butler
CFO
Mr. Franco Valle CPA
Address
900 Middlefield Road, Redwood City, CA, United States, 94063
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
107